Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. (LFCR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lfcr · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$6.00
+7.7% upside
Low
$6.00
Median: $6 · Last Close: $5.57
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.85 | ↑ 5.00% |
1-day model range: $5.81–$5.89. Peak: $5.89 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -1.9% |
| 2028 | $5 | -2.8% |
| 2029 | $5 | -3.2% |
| 2030 | $5 | -3.4% |
| 2031 | — | -3.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LFCR · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-29 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-03-27 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-03-24 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-03-17 | Barrington Research | Upgrade ↑ | Market Perform→Outperform |
| 2025-01-03 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2024-11-22 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-08-28 | Barrington Research | Downgrade ↓ | Outperform→Market Perform |
| 2023-09-01 | Barrington Research | Maintains | Outperform→Outperform |
| 2023-09-01 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2023-06-02 | Barrington Research | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Lifecore Biomedical, Inc. (LFCR) stock. Of the recent 29 rating actions, 3 were upgrades and 7 were downgrades. 7 analysts currently cover LFCR.
Analyst Recommendation Trends
LFCR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$75M
↓ 42.3% YoY
Revenue Next Year
$122M
↑ 62.6% YoY
EPS This Year
$-0.48
EPS Next Year
$-1.04
↑ 117.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast LFCR EPS of $-0.48 for the current fiscal year, based on estimates from 2 analysts. The LFCR revenue forecast is $75M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LFCR stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LFCR price target is $6.00 (+7.7% upside), with an analyst consensus of Buy.
The LFCR short-term stock prediction for tomorrow is $5.85 (+5.00%). The LFCR stock price prediction for 2027 estimates an average of $5. The LFCR stock prediction for 2030 projects a range of $5–$6.
Lifecore Biomedical, Inc. trades on NASDAQ under the ticker LFCR. The LFCR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 71% of covering analysts.
Frequently asked questions
LFCR forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month LFCR price target is $6.00, with a high forecast of $6.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +7.7% potential upside from the current price of $5.57.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.